Discovery of CDK4-selective molecular glue degraders by high-throughput proteomics
Patrick R. A. Zanon, Bachuki Shashikadze, Denise Winkler…·Henrik Daub
This study identifies a CDK4-selective molecular glue degrader, NE26394, using high-throughput proteomics, showing its efficacy in CDK4-dependent cancer models.